Teduglutide

Teduglutide is a recombinant analog of glucagon-like peptide-2 (GLP-2), approved for treating short bowel syndrome. It is studied for its ability to improve nutrient absorption and gut health.

In the literature, Teduglutide appears most often in work focused on gut health and healing. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.

Teduglutide is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.